Literature DB >> 28488596

The impact of microfluidic mixing of triblock micelleplexes on in vitro / in vivo gene silencing and intracellular trafficking.

Daniel P Feldmann1, Yuran Xie, Steven K Jones, Dongyue Yu, Anna Moszczynska, Olivia M Merkel.   

Abstract

The triblock copolymer polyethylenimine-polycaprolactone-polyethylene glycol (PEI-PCL-PEG) has been shown to spontaneously assemble into nano-sized particulate carriers capable of complexing with nucleic acids for gene delivery. The objective of this study was to investigate micelleplex characteristics, their in vitro and in vivo fate following microfluidic preparation of siRNA nanoparticles compared to the routinely used batch reactor mixing technique. Herein, PEI-PCL-PEG nanoparticles were prepared with batch reactor or microfluidic mixing techniques and characterized by various biochemical assays and in cell culture. Microfluidic nanoparticles showed a reduction of overall particle size as well as a more uniform size distribution when compared to batch reactor pipette mixing. Confocal microscopy, flow cytometry and qRT-PCR displayed the subcellular delivery of the microfluidic formulation and confirmed the ability to achieve mRNA knockdown. Intratracheal instillation of microfluidic formulation resulted in a significantly more efficient (p < 0.05) knockdown of GAPDH compared to treatment with the batch reactor formulation. The use of microfluidic mixing techniques yields an overall smaller and more uniform PEG-PCL-PEI nanoparticle that is able to more efficiently deliver siRNA in vivo. This preparation method may prove to be useful when a scaled up production of well-defined polyplexes is required.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28488596      PMCID: PMC5539944          DOI: 10.1088/1361-6528/aa6d15

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  38 in total

1.  Nanoparticle-mediated cellular response is size-dependent.

Authors:  Wen Jiang; Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

Review 2.  Recent advances in curcumin nanoformulation for cancer therapy.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Paul M Young; Daniela Traini; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Expert Opin Drug Deliv       Date:  2014-05-24       Impact factor: 6.648

Review 3.  Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?

Authors:  Andrei I Ivanov
Journal:  Methods Mol Biol       Date:  2008

4.  The advantages of pulmonary delivery of therapeutic siRNA.

Authors:  Daniel P Feldmann; Olivia M Merkel
Journal:  Ther Deliv       Date:  2015

5.  Amphiphilic biodegradable PEG-PCL-PEI triblock copolymers for FRET-capable in vitro and in vivo delivery of siRNA and quantum dots.

Authors:  Thomas Endres; Mengyao Zheng; Ayşe Kılıç; Agnieszka Turowska; Moritz Beck-Broichsitter; Harald Renz; Olivia M Merkel; Thomas Kissel
Journal:  Mol Pharm       Date:  2014-03-12       Impact factor: 4.939

6.  Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.

Authors:  Steven K Jones; Vincent Lizzio; Olivia M Merkel
Journal:  Biomacromolecules       Date:  2015-12-16       Impact factor: 6.988

Review 7.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.

Authors:  Dana J Gary; Nitin Puri; You-Yeon Won
Journal:  J Control Release       Date:  2007-05-26       Impact factor: 9.776

8.  Principles of nanoparticle design for overcoming biological barriers to drug delivery.

Authors:  Elvin Blanco; Haifa Shen; Mauro Ferrari
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

9.  Delivery of polyethylenimine/DNA complexes assembled in a microfluidics device.

Authors:  Chee Guan Koh; Xihai Kang; Yubing Xie; Zhengzheng Fei; Jingjiao Guan; Bo Yu; Xulang Zhang; L James Lee
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

10.  Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.

Authors:  Gerald Bachler; Sabrina Losert; Yuki Umehara; Natalie von Goetz; Laura Rodriguez-Lorenzo; Alke Petri-Fink; Barbara Rothen-Rutishauser; Konrad Hungerbuehler
Journal:  Part Fibre Toxicol       Date:  2015-06-27       Impact factor: 9.400

View more
  8 in total

1.  Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer.

Authors:  Daniel P Feldmann; Steven Jones; Kirk Douglas; Anthony F Shields; Olivia M Merkel
Journal:  Methods Mol Biol       Date:  2019

2.  Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.

Authors:  Tobias Wm Keil; Christoph Zimmermann; Domizia Baldassi; Friederike Adams; Wolfgang Friess; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2021-05-07

3.  Characterization of positively charged polyplexes by tunable resistive pulse sensing.

Authors:  Tobias W M Keil; Olivia M Merkel
Journal:  Eur J Pharm Biopharm       Date:  2020-12-15       Impact factor: 5.571

4.  Can pulmonary RNA delivery improve our pandemic preparedness?

Authors:  Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-28       Impact factor: 11.467

5.  Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy.

Authors:  Daniel P Feldmann; Joshua Heyza; Christoph M Zimmermann; Steve M Patrick; Olivia M Merkel
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

6.  Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery.

Authors:  Alexander Ewe; Sandra Noske; Michael Karimov; Achim Aigner
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

Review 7.  siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?

Authors:  Aditi Mehta; Thomas Michler; Olivia M Merkel
Journal:  Adv Healthc Mater       Date:  2021-01-27       Impact factor: 11.092

Review 8.  Inhaled RNA Therapy: From Promise to Reality.

Authors:  Michael Y T Chow; Yingshan Qiu; Jenny K W Lam
Journal:  Trends Pharmacol Sci       Date:  2020-09-04       Impact factor: 14.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.